# Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake

> **NCT04957082** · NA · COMPLETED · sponsor: **Michigan State University** · enrollment: 666 (actual)

## Conditions studied

- SARS-CoV2 Infection

## Interventions

- **BEHAVIORAL:** Culturally Targeted SARS-CoV-2 Communication
- **BEHAVIORAL:** General SARS-CoV-2 Communication

## Key facts

- **NCT ID:** NCT04957082
- **Lead sponsor:** Michigan State University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-04
- **Primary completion:** 2022-12-19
- **Final completion:** 2022-12-19
- **Target enrollment:** 666 (ACTUAL)
- **Last updated:** 2024-06-28

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04957082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04957082, "Culturally-Targeted COVID-19 Communication and SARS-CoV-2 Antibody Testing Evaluation and Uptake". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT04957082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*